Connection
Luis Juncos to Vasoconstrictor Agents
This is a "connection" page, showing publications Luis Juncos has written about Vasoconstrictor Agents.
|
|
Connection Strength |
|
|
|
|
|
0.372 |
|
|
|
-
Pelaez LI, Manriquez MC, Nath KA, Romero JC, Juncos LA. Low-dose angiotensin II enhances pressor responses without causing sustained hypertension. Hypertension. 2003 Oct; 42(4):798-801.
Score: 0.216
-
Nath KA, Hernandez MC, Croatt AJ, Katusic ZS, Juncos LA. Heme oxygenase activity as a determinant of the renal hemodynamic response to low-dose ANG II. Am J Physiol Regul Integr Comp Physiol. 2010 Nov; 299(5):R1183-91.
Score: 0.088
-
Belcher JM, Parada XV, Simonetto DA, Juncos LA, Karakala N, Wadei HM, Sharma P, Regner KR, Nadim MK, Garcia-Tsao G, Velez JCQ, Parikh SM, Chung RT, Allegretti AS. Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward. Am J Kidney Dis. 2022 05; 79(5):737-745.
Score: 0.048
-
Fu Y, Zhang R, Lu D, Liu H, Chandrashekar K, Juncos LA, Liu R. NOX2 is the primary source of angiotensin II-induced superoxide in the macula densa. Am J Physiol Regul Integr Comp Physiol. 2010 Mar; 298(3):R707-12.
Score: 0.021
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|